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Background: Macrophages play pivotal roles in the progression of atherosclerosis (AS) and their heterogeneous
differentiation patterns have been studied extensively. The classical subtype of activated macrophage, M1,
promotes the progression of AS. Conversely, the alternative subtype of activated macrophage, M2, is regarded as a
repressor of AS. Homocysteine (Hcy) may influence macrophage subtype polarization both in vivo and in vitro.
Homocysteinemia (HHcy) is an independent risk factor in coronary heart disease and the effect of Hcy on
macrophage differentiation has not been studied until now.
Methods: Different concentrations of Hcy in combination with a fixed concentration of lipopolysaccharide
(LPS, 200 ng/mL) were used to treat RAW264.7 macrophages. Real-time PCR was used to detect and quantify RNA
transcripts indicative of M1 and M2 differentiation. The efficacy and specificity for each chemical stimulant in
inducing macrophage differentiation were also investigated. The M2 macrophages (anti-inflammatory subtype)
induced using classical methods (IL-4, 10 ng/mL) were also treated with different concentrations of Hcy complemented
with LPS. The synergistic effect of Hcy and LPS in the converting the M2 subtype to M1 was also studied.
Results: Macrophages can be induced to differentiate towards M1 by a combination of Hcy with LPS, with the
strongest effect observed at an Hcy concentration of 50 μmol/L. After inducing macrophages to the M2 subtype
using IL-4, treatment with both Hcy and LPS could elicit conversion from the M2 to M1 subtype.
Conclusion: Combined treatment with Hcy and LPS can induce the polarization of cultured RAW264.7
macrophages into the pro-inflammatory subtype, as well as promote subtype conversion from anti-inflammatory
to pro-inflammatory.
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Atherosclerosis (AS) is a chronic and progressive inflamma-
tory disease characterized by the accumulation of lipids and
fibrous lesions in the large arterial intima. Mechanisms
governing AS continue to draw extensive research interest.
Among proposed mechanisms, the immuno-inflammation
hypothesis has become accepted by most researchers [1-3].
Macrophages are important in both the initiation and
progression of AS [4,5]. Macrophages can differentiate
into two subtypes (M1 and M2) in response to micro-
environmental changes. Considered the classical activated* Correspondence: zuyiyuan@mail.xjtu.edu.cn
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reproduction in any medium, provided the orsubtype, M1 exerts pro-inflammatory effects that promote
the progression of AS. In contrast, the M2 activated
subtype exerts anti-inflammatory effects and is regarded
as a repressor of AS [6,7].
Hyperhomocysteinemia (HHcy, abnormally high physio-
logical levels of homocysteine, Hcy) is regarded as an inde-
pendent risk factor in coronary heart disease, although the
exact mechanism of how Hcy induces AS is unclear.
Studies have shown that Hcy can promote AS occurrence
and progression through oxidative stress damage, endo-
thelial damage, and activation of inflammatory and im-
mune responses [8,9]. A positive correlation between HHcy,
endothelial dysfunction, and accelerated AS has been dem-
onstrated by using gene-induced and diet-induced HHcy. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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that Hcy could induce monocyte/macrophage localization
in inflammatory lesions and exert pro-AS effects. Addition-
ally, researchers have found that Hcy can influence the
differentiation of macrophages both in vivo and in vitro
[11]. However, it is unclear if the effect of Hcy on macro-
phage polarization and subtype conversion correlates to
its pathogenic role in AS.
Materials and methods
Cell culture
The RAW264.7 macrophage cell line was provided by the
Cardiology Institute of the First Affiliated Hospital of
Medical College, Xi’an Jiaotong University [12]. RAW264.7
cells were cultured in DMEM supplemented with 10%
(vol/vol) FBS, penicillin (100 U/mL) and streptomycin
(100 μg/mL). In a 6-well round bottom plate, 1 × 106 cells
per well were seeded and incubated at 37°C for 12 hours. Be-
fore stimulation by Hcy and LPS, cells were serum-starved
by culturing in DMEM without 10% FBS for 12 hours.
Reagents
Hcy and LPS were from Sigma (Milwaukee, USA). IL-4
was from Peprotech (Rocky Hill, USA). The upstream and
downstream primers of GAPDH, IL-6, IL-10, TNF-α, iNOS,
Arg-1, and MMR (shown in Table 1) were synthesized
by Beijing Augct Biotechnology Co., Ltd. (Beijing, China).
The RNA Fast 200 kit was from Shanghai Flytech
Biotechnology Co., Ltd (Shanghai, China). The RevertAid™
First Strand cDNA Synthesis Kit was from Fermentas
(Vilnius, Lithuania). SYBR Premix Ex Taq™ II was from
TaKaRa (Dalian, China).Table 1 Sequences of real-time PCR primers
Genes Primers
GAPDH F (5′-3′) TCA ACG GCA CAG TCA AGG
R (5′-3′) ACT CCA CGA CAT ACT CAG C
IL-6 F (5′-3′) AGC CAG AGT CCT TCA GAG AGA TAC
R (5′-3′) AAT TGG ATG GTC TTG GTC CTT AGC
TNF-α F (5′-3′) GCT CTT CTG TCT ACT GAA CTT CGG
R (5′-3′) ATG ATC TGA GTG TGA GGG TCT GG
iNOS F (5′-3′) CCC TTC CGA AGT TTC TGG CAG CAG C
R (5′-3′) CCA AAG CCA CGA GGC TCT GAC AGC C
IL-10 F (5′-3′) GGT TGC CAA GCC TTA TCG TA
R (5′-3′) ACC TGC TCC ACT GCC TTG CT
Arg-1 F (5′-3′) ATG CTC ACA CTG ACA TCA ACA CTC
R (5′-3′) CTC TTC CAT CAC CTT GCC AAT CC
MMR F (5′-3′) CAT GAG GCT TCT CCT GCT TCT G
R (5′-3′) TTG CCG TCT GAA CTG AGA TGG
F: forward primer; R: reverse primer.RNA isolation and real-time PCR
Total RNA was isolated with the RNA Fast 200 kit accord-
ing to the manufacturer’s instructions. First-strand cDNA
was synthesized with the RevertAid™ First Strand cDNA
Synthesis Kit and analyzed by real-time quantitative PCR
with SYBR Premix Ex Taq™ II. PCR was performed on the
IQ5™ Multicolor real-time PCR and detection system
(Bio-Rad, Hercules, CA, USA). Data were analyzed on the
basis of relative expression method using the formula ΔΔC
expression = 2–ΔΔCt, where ΔΔCt =ΔCt (treated group) –
ΔCt (control group), ΔCt =Ct (target gene) – Ct (GAPDH),
and Ct = cycle at which the threshold is reached.
Statistical analysis
Data were analyzed with SPSS for Windows (version 18.0)
using one-way ANOVA. Unless otherwise stated, graphs
show mean ± SD. For each dataset, p < 0.05 was considered
statistically significant.
Results
Effects of Hcy and LPS on mRNA expression in macrophages
Different concentrations of Hcy (0, 20, 50 and 100 μmol/L)
combined with a fixed concentration of LPS (200 ng/mL)
were tested. The mRNA levels of M1 markers (IL-6,
TNF-α, and iNOS) were up-regulated by the 12-hour
treatment with different concentrations of Hcy combined
with LPS. mRNA expression levels of these genes reached
their maxima at an Hcy concentration of 50 μmol/L
(Figure 1). Expression of M2 marker genes did not change
significantly in response to the combined Hcy/LPS treat-
ment (data not shown).
Time effect of Hcy and LPS treatment on mRNA
expression in macrophages
M1-associated genes reached their highest mRNA expres-
sion levels at an Hcy concentration of 50 μmol/L. To deter-
mine if Hcy affects expression of M1-associated genes in a
time-dependent manner, we measured the corresponding
mRNA transcript levels at different time points. When cells
were treated with 50 μmol/L Hcy and 200 ng/mL LPS,
mRNA expression of IL-6, TNF-α, and iNOS peaked after
12, 24, and 24 hours, respectively (Figure 2).
Effects of Hcy and LPS on mRNA expression in
M2 macrophages
Because the combination of Hcy and LPS could induce
macrophage differentiation towards the M1 subtype, we
were compelled to investigate if similar treatment could
convert the M2 subtype into M1. RAW264.7 macro-
phages were first induced into the M2 subtype using
IL-4 (10 ng/mL) for 12 hours. The three M2 markers
(IL-10, Arg-1, and MMR) were up-regulated, whereas
the M1 markers (IL-6, TNF-α, and iNOS) were down-
regulated, indicating the successful polarization to M2.
Figure 1 Effects of Hcy and LPS on mRNA expression of M1 marker genes. (A) IL-6, (B) TNF-α and (C) iNOS mRNA expression at 12 h were assessed
by real-time PCR. Gene expression is represented as fold-change compared to unstimulated macrophage. Data are representative of three independent
experiments. (uns: unstimulated macrophages; *p< 0.05 vs uns, #p< 0.05 vs LPS, Δp< 0.05 vs LPS +Hcy 20 μmol/L, &p< 0.05 vs LPS +Hcy 50 μmol/L).
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ferent concentrations of Hcy and a fixed concentration
for 12 hours. After treatment, the gene expression of
M2 markers decreased, whereas the gene expression of
M1 markers increased (Figure 3).
Time effect of Hcy and LPS on mRNA expression in
M2 macrophages
To find out whether the effect of combined Hcy and
LPS treatment on mRNA expression in M2 macrophages
is time-dependent, a combination of 50 μmol/L Hcy and
LPS (200 ng/mL) was used to treat M2 macrophages
arising from IL-4 induction. mRNA expression levels of
IL-6, TNF-α, and iNOS reached their maxima after 6,
12, and 12 hours, respectively. In contrast, the expression
of IL-10, Arg-1, and MMR declined after prolonged incuba-
tion with the combined treatment (Figure 4).
Discussion
Macrophages are considered to be important immune
effector cells. Recent studies have uncovered plasticity andFigure 2 Time effect of Hcy and LPS on mRNA expression of M1 mark
assessed by real-time PCR. Gene expression is represented as fold-change c
three independent experiments. (uns: unstimulated macrophages; *p < 0.05heterogeneity in their differentiation pathways, as dem-
onstrated by changes in cellular phenotype and physiology
in response to micro-environmental stimuli. Mirroring
the Th1/Th2 nomenclature, polarized macrophages are
categorized into M1 and M2 subtypes. The classical sub-
type of activated macrophages, M1, can initiate adaptive
immune responses and produce various pro-inflammatory
cytokines. These biochemical responses are often involved
in killing microorganisms and tumor cells. Moreover, M1
macrophages can promote atherosclerosis (AS). The al-
ternative activated subtype, M2, also plays various roles,
such as directing Th2 humoral response, killing parasites,
repairing tissues, and producing anti-inflammatory cyto-
kines. M2 macrophages are regarded as inhibitors of AS.
However, it is noteworthy that the distinction between M1
and M2 macrophages may not be absolutely definitive;
many researchers consider the M1 and M2 subtypes as
opposing extremes of the macrophage spectrum [13].
The classical activation of M1 macrophages by interferon-
γ (IFN-γ) and LPS creates cells that can produce various
pro-inflammatory chemokines and cytokines such as IL-6ers genes. (A) IL-6, (B) TNF-α and (C) iNOS mRNA expression were
ompared to unstimulated macrophage. Data are representative of
vs uns, #p < 0.05 vs 6 h, Δp < 0.05 vs 12 h, &p < 0.05 vs 24 h).
Figure 3 Effects of Hcy and LPS on mRNA expression in M2 macrophage. (A) IL-6, (B) TNF-α, (C) iNOS, (D) IL-10, (E) Arg-1 and (F) MMR
mRNA expression were assessed by real-time PCR. Gene expression is represented as fold-change compared to unstimulated macrophages. Data
are representative of three independent experiments. (uns: unstimulated macrophages; Arg stands for Arg-1; *p < 0.05 vs uns; #p < 0.05 vs IL-4;
Δp < 0.05 vs LPS; &p < 0.05 vs LPS + Hcy 20 μmol/L; $p < 0.05 vs LPS + Hcy 50 μmol/L).
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produce anti-inflammatory cytokines such as IL-10. Aside
from their differential expression of opposing effector mole-
cules, inducible nitric oxide synthase (iNOS) is expressed
more in M1 macrophages, whereas arginase-1 (Arg-1) and
mannose membrane receptor (MMR) are expressed more
in M2 macrophages, reflecting the different immunological
roles of these two populations [7]. In this study, we chose
IL-6, TNF-α, and iNOS as M1 macrophage markers, whose
expression was induced by IFN-γ and LPS. We chose
IL-10, Arg-1, and MMR as M2 macrophage markers,
whose expression was induced by IL-4. These results
are consistent with our previous work [12].
LPS, the primary glycolipid component found in the
outer membranes of Gram-negative bacteria, can induce
inflammatory responses, activate the complement system,
and initiate the coagulation pathway [14]. Many studies
have confirmed that in the presence of IL-1 or IFN-γ, theLPS-induced defense reaction and killing ability could be
augmented. Conversely, the pro-inflammatory effect of
IFN-γ can be enhanced by the presence of LPS [15,16].
Because we had been unable to stimulate macrophage
subtype polarization using Hcy alone (data not shown),
we decided to use a combination of Hcy and LPS.
In the presence of LPS, Hcy led to up-regulated expres-
sion of M1 macrophage markers (IL-6, TNF-α, and iNOS);
the optimal Hcy concentration was 50 μmol/L. However,
Hcy and LPS elicited no significant effects on the expres-
sion of M2 macrophage markers (IL-10, Arg-1, and MMR).
No correlation between the concentration of Hcy and the
expression of marker genes was observed. This was
possibly due to higher Hcy concentrations leading to
more cell death. We also found that a combination of
Hcy and LPS could transform M2 subtype into M1. This
phenomenon may help to explain the pro-atherosclerotic
effects of Hcy.
Figure 4 Time effect of Hcy and LPS on mRNA expression in M2 macrophage. (A) IL-6, (B) TNF-α, (C) iNOS, (D) IL-10, (E) Arg-1 and (F) MMR
mRNA expression were assessed by real-time PCR. Gene expression is represented as fold-change compared to unstimulated macrophages. Data
are representative of three independent experiments. (uns: unstimulated macrophages; Arg stands for Arg-1; *p < 0.05 vs uns; #p < 0.05 vs 6 h;
Δp < 0.05 vs 12 h; &p < 0.05 vs 24 h).
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of AS by activating inflammatory immune reactions. The
immuno-inflammation hypothesis is a generally accepted
explanation for the mechanism of AS, and macrophages
are believed to be important in this process. The differ-
entiation of macrophages into different sub-populations
has become a new exploratory area in the initiation and
progression of AS. Zhang et al. have demonstrated that
Hyperhomocysteinemia (HHcy) could accelerate AS
and enhance Ly-6C Monocyte/Macrophage accumula-
tion in the lesions of Tg-hCBS apoE−/−Cbs−/− mice.
They also found that monocyte/macrophage accumu-
lation in the lesions of Ly-6C-positive mice correlated
positively with Hcy levels. However, little is known
about the influence of Hcy on the polarization of cultured
macrophages [17]. In this study, we used a cell-based assay
to demonstrate that Hcy could induce macrophage
polarization into the pro-inflammatory phenotype, thereby
providing further evidence in support of the model for
Hcy-induced AS.
Conclusions
We investigated the synergistic effects of Hcy and LPS
on the differentiation and conversion of RAW264.7
macrophages. The results showed that a combination
of Hcy and LPS could induce macrophages to differen-
tiate into the pro-inflammatory subtype. The differentiated
anti-inflammatory subtype could also be converted tothe pro-inflammatory subtype by combined treatment
with Hcy and LPS. These findings provide new evidence
for the role of Hcy in facilitating the progression of AS.
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